Analysis UBS ETF SICAV - MSCI Canada UCITS ETF (0HBI)
5/30/2024
Analysis of UBS ETF SICAV - MSCI Canada UCITS ETF (0HBI)
The UBS ETF SICAV - MSCI Canada UCITS ETF (0HBI) has shown a generally positive trend in recent trading days.- The Relative Strength Index (RSI) has been consistently above 50, indicating bullish momentum. The RSI values have been in the range of 67 to 81, suggesting that the asset may have been overbought at times but still showing strength.
- The Moving Average Convergence Divergence (MACD) indicator has been positive, with the MACD line consistently above the signal line. The MACD histogram has also been mostly positive, indicating upward momentum.
- The Moving Average (MA) indicator has been trending upwards, with the Simple Moving Average (SMA), Exponential Moving Average (EMA), and Weighted Moving Average (WMA) all showing an increasing trend.
Overall, based on these indicators, the UBS ETF SICAV - MSCI Canada UCITS ETF (0HBI) appears to be in a bullish phase, with positive momentum and potential for further price appreciation. However, investors should always consider other factors and conduct a comprehensive analysis before making investment decisions.
Revenue estimate
Based on the analysts' estimates for the future quarterly and annual sales of the company, we can draw the following conclusions:1. For the current quarter ending on June 30, 2024, the average sales estimate is $83,776,900,000, with a sales growth of 2% compared to the same quarter last year. The number of analysts providing estimates is 24.
2. For the next quarter ending on September 30, 2024, the average sales estimate is $92,375,300,000, with a sales growth of 3% compared to the same quarter last year. The number of analysts providing estimates is 24.
3. For the current fiscal year ending on September 30, 2024, the average sales estimate is $386,681,000,000, with a sales growth of 1% compared to the previous fiscal year. The number of analysts providing estimates is 37.
4. For the next fiscal year ending on September 30, 2025, the average sales estimate is $411,555,000,000, with a sales growth of 6% compared to the current fiscal year. The number of analysts providing estimates is 37.
These estimates suggest a moderate growth trend in both quarterly and annual sales for the company over the specified periods.
Growth estimates
Based on the consensus estimates provided:- The current year growth rate is 7.5%
- The next quarter growth rate is 4.8%
- The current quarter growth rate is 5.6%
- The next year growth rate is 9.7%
- The next 5 years compound annual growth rate (CAGR) is 11%
- The past 5 years compound annual growth rate (CAGR) is 20.15%
From these estimates, we can see that the company is expected to experience a significant increase in growth compared to the past 5 years, with a particularly strong growth rate projected for the next 5 years. The current and next quarter growth rates also indicate positive momentum in the short term.
Price target
The analysts' forecast for the future price of the security paper is as follows:- Low: $164
- High: $250
- Median: $200
- Average: $202.26
- Current price: $191.57
- Currency: USD
Based on these forecasts, we can see that the analysts have a range of opinions regarding the future price of the security paper, with the low end at $164, the high end at $250, and the average at $202.26. The current price is below both the average and median forecast, indicating a potential opportunity for growth according to the analysts' predictions.
Earnings
The company's results for the most recent quarter, ending on April 30, 2025, have not been provided at this time. The previous results were reported on February 27, 2025, by the Transfer Agent. Before that, on January 31, 2025, the results were released after hours. The results from October 31, 2024, were not provided at the time. On August 1, 2024, the company reported an earnings per share (EPS) estimate of 1.32.Main Statystic ðŸ§
The data provides a comprehensive overview of the financial and stock-related metrics for a company. Here are the key points:1. **Financials**:
- **Cash Flow**: Operating cash flow for the trailing twelve months (TTM) is $110,563,000,320, and levered free cash flow TTM is $84,726,874,112.
- **Balance Sheet**: Total cash on a most recent quarter (MRQ) basis is $67,150,000,128, total debt MRQ is $104,590,000,128, current ratio MRQ is 1.037, book value per share MRQ is $4.837, total cash per share MRQ is $4.379, and total debt to equity MRQ is 140.968.
- **Profit Margin**: The profit margin is 26.306%.
- **Income Statement**: EBITDA is $131,393,000,000, revenue TTM is $381,623,009,280, diluted EPS TTM is $6.43, gross profit TTM is $169,148,000,000, revenue per share TTM is $24.537, net income to common TTM is $100,389,003,264, quarterly revenue growth is -4.3%, and quarterly earnings growth year-over-year is -2.2%.
- **Operating Margin**: The operating margin is 30.743%.
- **Return on Assets (ROA)**: ROA TTM is 22.073999%.
- **Return on Equity (ROE)**: ROE TTM is 147.25%.
2. **Stock Statistics**:
- **Short Ratio**: 1.53
- **Float Shares**: 15,308,320,742
- **Shares Short**: 99,287,450
- **Average 10-Day Volume**: 46,860,048
- **Average 90-Day Volume**: 57,498,254
- **Shares Outstanding**: 15,334,099,968
- **Percent Held by Insiders**: 5.22%
- **Percent Held by Institutions**: 57.589%
- **Short Percent of Shares Outstanding**: 0.65%
3. **Valuations Metrics**:
- **PEG Ratio**: 26.319502
- **Forward PE Ratio**: 26.319502
- **Trailing PE Ratio**: 29.59409
- **Enterprise Value**: $2,950,762,332,160
- **Price to Book MRQ**: 39.3405
- **Price to Sales TTM**: 7.646095
- **Enterprise to EBITDA**: 22.763
- **Enterprise to Revenue**: 7.732
- **Market Capitalization**: $2,917,925,650,432
4. **Stock Price Summary**:
- **Beta**: 1.264
- **50-Day Moving Average**: $176.2646
- **200-Day Moving Average**: $181.0429
- **52-Week Low**: $164.08
- **52-Week High**: $199.62
- **52-Week Change**: 6.853%
5. **Dividends and Splits**:
- **Payout Ratio**: 14.93%
- **Dividend Date**: May 16, 2024
- **Last Split Date**: August 31, 2020
- **Ex-Dividend Date**: May 10, 2024
- **Last Split Factor**: 4-for-1 split
- **Forward Annual Dividend Rate**: $1
- **5-Year Average Dividend Yield**: 0.73%
- **Forward Annual Dividend Yield**: 0.5255%
- **Trailing Annual Dividend Rate**: $0.97
- **Trailing Annual Dividend Yield**: 0.5097%
Income statement 💸
These are the revenues. Here are the conclusions:1. The company's sales revenue has been increasing steadily over the years, from $274.5 billion in 2020 to $383.3 billion in 2023.
2. Despite fluctuations in other financial metrics, the sales revenue has shown a consistent upward trend.
3. The company has managed to grow its top line consistently, indicating strong market demand for its products or services.
4. Increasing sales revenue can be a positive indicator of the company's overall financial health and growth potential.
Balance Sheet
These are balance sheets. Here are the conclusions:1. The total assets have been increasing over the years, reaching $365,725,000,000 in 2018.
2. Current assets have fluctuated, with the highest value in 2019 at $162,819,000,000.
3. Non-current assets have shown an increasing trend, with the highest value in 2019 at $175,697,000,000.
4. Total liabilities have also been increasing, reaching $255,355,000,000 in 2018.
5. Shareholders' equity has shown an increasing trend, with the highest value in 2018 at $107,147,000,000.
6. The company has been relying more on non-current assets to support its operations.
7. There has been a consistent increase in shareholders' equity, indicating a positive trend in the company's financial health.
Cash Flow 💶
This is a cash flow statement. Here are some conclusions we can draw from the data:1. The company's free cash flow has been fluctuating over the years, with the highest value in 2022 and the lowest in 2020.
2. Operating cash flow has generally been increasing year over year, indicating improved operational efficiency.
3. The company has been consistently paying interest and income taxes, with varying amounts each year.
4. Financing activities show significant fluctuations, especially in common stock repurchases and long-term debt issuuance.
5. Investing activities also vary, with notable amounts spent on the sale and purchase of investments.
6. The end cash position has been fluctuating, but generally, the company has maintained a healthy cash balance.
7. The company has been paying dividends consistently, with varying amounts each year.
8. Stock-based compensation has also been a significant expense for the company.
9. Overall, the company's cash flow statement reflects a mix of stable and fluctuating financial activities, indicating a dynamic financial position.
Earnings estimate
The analysts' estimates for future quarterly and annual earnings per share are as follows:1. Current Quarter (as of June 30, 2024):
- Average Estimate: $1.33
- Low Estimate: $1.27
- High Estimate: $1.36
- Number of Analysts: 26
- Year Ago EPS: $1.26
2. Next Quarter (as of September 30, 2024):
- Average Estimate: $1.53
- Low Estimate: $1.44
- High Estimate: $1.63
- Number of Analysts: 25
- Year Ago EPS: $1.46
3. Current Year (as of September 30, 2024):
- Average Estimate: $6.59
- Low Estimate: $6.43
- High Estimate: $6.92
- Number of Analysts: 39
- Year Ago EPS: $6.13
4. Next Year (as of September 30, 2025):
- Average Estimate: $7.23
- Low Estimate: $6.40
- High Estimate: $7.90
- Number of Analysts: 39
- Year Ago EPS: $6.59
Based on these estimates, we can see a generally positive outlook with an increase in earnings per share expected for both the current and next year compared to the previous year. The number of analysts providing estimates also indicates a strong interest in the company's performance.
This is not investment advice. Remember to verify the information provided here.
Get access to the full analysis
- Over 35 000 indexes
- CFD, Forex, Crypto and Stocks Exchange
- Over 150 Indicators
- Pattern and candle analysis
- Support and resistance levels
- Fundamental, technical and sentimental analysis
- Power from AI
